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Abstract. A novel simple kinetic spectrophotometric method for the determination of N-acetyl-L-cysteine 
(NAC) has been developed and validated. The proposed method is based on the reduction of CuII-
neocuproine reagent to CuI-neocuproine with the analyte, in a Britton-Robinson buffer solution (pH = 
3.0). The non-steady state absorbance of the formed CuI-neocuproine complex is measured at 458 nm. 
The initial rate and fixed time (at 1 min) methods were utilized for constructing the calibration graphs. 
The calibration curves for both methods were linear in concentration range from 6.0  10–7 to 8.0  10–5 
mol L–1 with the limit of detection 1.7  10–7 mol L–1. The slope of the initial method calibration curve 
(1.0181) confirmed the first order reaction. Both proposed methods were successfully applied for the de-
termination of NAC in its commercial pharmaceutical formulations. (doi: 10.5562/cca2161)  
Keywords: N-acetyl-L-cysteine, Kinetic spectrophotometry, Initial rate method, Fixed time method, Phar-
maceutical analysis  
 
INTRODUCTION 
N-acetyl-L-cysteine (acetylcysteine, NAC) is a synthetic 
aminothiol antioxidant used in medicine as a mucolytic 
agent with the aim of reducing the viscosity of pulmo-
nary secretions in a variety of respiratory illness. Intra-
venous administration of NAC is used extensively in the 
management of paracetamol (acetaminophen) poison-
ing. Further more, NAC is a physiological substance.1 
The European Pharmacopeia recommended 
iodimetric titration for pharmaceutical formulations 
analysis.2 Other reported methods described in the liter-
ature comprise: titrimetry,3,4 spectrophotometry,5–9 
fluorimetry,10–12 chromatography,13,14 potentiometry,15 
conductometry16 and voltametry17–19 for the determina-
tion of NAC in pure form, in dosage forms and in bio-
logical samples. 
However, these methods are not sufficiently sen-
sitive and selective, or some of them require expensive 
instrumentation and are too expensive for routine 
analysis.  
Kinetic methods are a powerful tool for drug anal-
ysis as they permit sensitive and selective determination 
using affordable detectors within a few minutes with no 
sample pre-treatment in many cases. In fact, by using 
kinetic method determination of an analyte in a mixture 
may be possible when analyte and other species in mix-
ture have sufficient differences of reaction rates. In our 
laboratory we research kinetic methods of analysis by 
using potentiometric and spectrophotometric detectors, 
almost forty years. In the first published kinetic analyti-
cal method a commercial fluoride ion-selective elec-
trode as potentiometric sensor was used.20 Our research 
team has published two kinetic potentiometric methods 
for the NAC determination.21,22 In addition, spectropho-
tometric technique is the most widely used in pharma-
ceutical analysis, due to its inherent simplicity, econom-
ic advantage, and wide availability in the most quality 
control laboratories. The application of kinetic spectro-
photometric methods offers some specific advantages 
over classical spectrophotometry, such as improved 
selectivity due to the measurement of the evolution of 
the analytical signal (absorbance) with the reaction time. 
The literature is still poor in analytical procedures based 
on kinetic spectrophotometry for the determination of 
the examined analyte. Beside two kinetic spectrophoto-
metric methods for the determination of NAC devel-
oped by our team,23,24 there are only two published 
kinetic spectrophotometric methods.25,26  
In this report a novel simple and sensitive kinetic 
spectrophotometric method with the chromogenic rea-
gent, copper(II)-neocuproine for the determination of 
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NAC is described and validated. Ease of the application, 
sensitivity, short analysis time, low cost and reliability 
are its main advantages. The initial rate and fixed time 
methods, after their optimization and validation, are 
adopted for the determination of NAC in its pharmaceu-




All chemicals were of analytical-reagent grade and 
solutions were prepared in deionised water (Milli Q, 
Millipore, Saint Quentin, Yvelines, France). 
A stock solution of NAC 1.0  10–2 mol L–1 was 
prepared by dissolving 13.2 mg of NAC (Merck, Darm-
stadt, Germany) in Britton-Robinson buffer solution 
(pH = 3.0) up to 100.0 mL in volume and stored at 4 °C 
in the dark bottle. Working solutions of NAC were 
prepared daily by dilution of the stock solution with 
deionised water. 
A stock solution of CuII 1.0  10–2 mol L–1 was 
prepared by dissolving 250.0 mg of copper sulphate 
pentahydrate (Kemika, Zagreb, Croatia) in a 100.0 mL 
of a deionised water. 
Since neocuproine (2,9-dimethyl-1,10-phenantro-
line) is slightly soluble in water, the stock solution of 
lower concentration, 1.0  10–3 mol L–1, was prepared. 
A 20,8 mg of neocuproine (Sigma-Aldrich, Steinheim, 
Germany) was transferred to a 100.0 mL volumetric 
flask, and about 90.0 mL of deionised water was added. 
The closed volumetric flask with the content was treated 
in the ultrasonic bath for at least 30 minutes and after-
ward filled to the mark with deionised water. 
Solubility of neocuproine is improved in the mixture 
with the CuII because the complex [Cu(neocuproine)2]
2+  
is formed.27 The molar ratio of neocuprione and CuII in 
the reaction mixture was determined in the optimization 
part of the experiment. According to these results the 
copper(II)-neocuproine reagent was prepared as fol-
lows: 25.0 mg of copper sulphate pentahydrate and 50.0 
mg of neocuproine were dissolved in the 100.0 mL of 
deionised water. The molar ratio of neocuproine: CuII 
was 2.4 : 1. The dissolving process was enhanced by 
sonication for about 15 minutes. Copper (II)-neocupro-
ine reagent was stable for at least 30 days stored at 4 °C. 
Britton-Robinson buffer solution (Acetic/Boric/ 
Phosphoric acid buffer solution) was prepared by mixing 
acetic, boric and phosphoric acids of final concentrations 4 
 10–2 mol L–1 (pH is about 2) and adjusting the pH value 
by adding sodium hydroxide solution, c = 2.0 mol L–1. 
Adjustments and measurements of pH were carried out 
with a Mettler Toledo SevenMulti potentiometer (Mettler 
Toledo, Schwerzenbach, Switzerland) equipped with com-
bined glass electrode Mettler Toledo InLab®413. 
Sample Preparation 
The commercial pharmaceutical formulations analysed 
by proposed kinetic spectrophotometric method were 
granules, Fluimukan 100 mg, syrup, Fluimukan Akut 
Junior and dispersible tablets, Fluimukan Akut 600 mg, 
all produced by Lek d.d., Ljubljana, Slovenia. The solu-
tions of pharmaceutical products were prepared by dis-
solving suitable amounts of the commercial samples in 
Britton-Robinson buffer solution (pH = 3.0) and diluting 
the resulting solution, with the deionised water, to adjust 
the concentration required by the adopted experimental 
conditions. 
For the validation part of the experiments an io-
dine solution, 0.5 mol L–1, was prepared and standard-
ized according to the literature.2 
 
Instrumentation 
The kinetic manifold for spectrophotometric determina-
tion consisted of an Ismatec IPC eight-channel peristal-
tic pump (Ismatec, Zurich, Switzerland) and Shimadzu 
UV-1601 (Shimadzu, Kyoto, Japan) UV-Vis spectro-
photometer equipped with a Hellma (Jamaica, NY) flow 
cell of 160 μL internal volume and 10 mm optical path. 
The spectrometric instrument was set at 458 nm for all 
absorbance measurements. The kinetic manifold has 
been described in more details previously.24 
 
Procedure 
For the determination of NAC, a mixture of reagents 
was prepared as follows. In a reaction vessel with  
6.0 mL of Britton-Robinson buffer solution (pH = 3.0), 
2.5 mL of copper(II)-neocuproine reagent and 15.5 mL 
of deionized water were added. In this reagent solution, 
1 min after beginning of a measurement, a 1.0 mL por-
tion of the analyte or sample was added to start the 
reaction. The final volume of the reaction solution in the 
thermostated vessel (25 °C) was 25.0 mL. At a flow rate 
of 6 mL min–1 and λ = 458 nm, the absorbance of the 
produced [Cu(neocuproine)2]
+ complex was continuous-
ly recorded as the function of time. The frequency of 
data recording was 1 s–1. 
 
Data Acquisition and Processing 
The recorded kinetic data were transformed to a 
GraphPad Prism Ver. 4.03 for Windows (GraphPad 
Software, San Diego, CA) for curve fitting, regression 
analysis and statistical calculations. The initial rate and 
fixed time methods were utilized for constructing the 
calibration graphs. Initial reaction rates (K) were deter-
mined from the slopes of the absorbance-time curves. 
The logarithms of the reaction rates were plotted as a 
function of logarithms of NAC concentrations. The 
graph of the fixed time method was constructed by 
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plotting the absorbance measured at a fixed time versus 
c (NAC). A fixed time interval of 1 min was selected 
since linearity was additionally improved. 
 
RESULTS AND DISCUSSION 
The proposed method is based on the redox reaction 
(Equation (1)) in which NAC (RSH compound) re-
duces CuII-neocuproine complex to orange-yellow  
CuI-neocuproine complex:27 
2RSH  +  2[Cu(neocuproine)2]
2+   
RSSR  +  2[Cu(neocuproine)2]
+  +  2H+ (1) 
The spectrum of CuI-neocuproine complex (refer-
ence cell: deionised water) and CuII-neocuproine complex 
are shown in the Figure 1 curve (a) and (b), respectively.  
The proposed redox reaction is very fast. However 
the coloured product of the reaction is rather unstable 
probably due to oxidation of CuI with the oxygen from 
the air (Figure 2). Therefore it is very important to meas-
ure the signal in the kinetic part of the reaction i.e. under 
dynamic conditions in which the concentrations of reac-
tants and products are changing as a function of time. 
 
Optimization of the Reaction Conditions 
The effect of the pH was investigated over the range  
2.0 – 8.0 using Britton-Robinson buffer solution. The 
appropriate pH values were adjusted by adding sodium 
hydroxide solution, c = 2.0 mol L–1. 
Although the reaction rates and the absorbances  
did not significantly change for the broad scale of the pH 
values in the first minute of the reaction, the signal was 
more stable at lower pH values. Besides, NAC is more 
stable at lower pH values. Therefore, a buffered reaction 
medium of pH = 3.0 was chosen for the further measuring. 
Molar ratio of CuII and neocuproine in the reaction 
mixture was investigated. During the optimization ex-
periment, the concentration of CuII maintained constant, 
(1.0 × 10–4 mol L–1), and the concentration of neocupro-
ine was changed in range: 1.0 × 10–4 mol L–1 to 3.5× 10–4 
mol L–1. Accordingly, the molar ratio of neocuproine / 
CuII has changed from 1.0 to 3.5. The results show that 
by increasing the neocuproine concentration, the reaction 
rate and the absorbance increased and reached a constant 
value when molar ratio of neocuproine / CuII was 2.4. 
The effect of the reaction temperature on the signal 
intensity was examined by varying the temperature of the 
thermostated reaction vessel in range from 20 to 40°C.  
The results showed that the proposed redox reac-
tion is temperature independent in this range. The rate 
of the reaction and the stability of the signal remained 
the same in the wide temperature range. The reproduci-
bility of measuring the same concentration of analyte at 
different temperatures was satisfying and the relative 
standard deviation was lower then 0.5%. Therefore, 
experiment can be performed at laboratory temperature 
so the kinetic manifold does not need to be thermostated 
during measurement. 
 
Kinetics of the Reaction 
Under the above-described optimum conditions, the 
absorbance-time curves for the reaction at varying NAC 
concentrations (6.0 × 10–7 to 8.0 × 10–5 mol L–1) with a 
fixed analytical concentrations of CuII (1.0  10–4 mol 
L–1) and neocuproine (2.4  10–4 mol L–1) were generat-
ed (Figure 2).  
 
Quantitation Methods 
Initial Rate Method. 
According to experimental data, the initial rates of the 
proposed reaction with NAC would follow a pseudo-
Figure 1. Spectra of: (a) Copper(I)-neocuproine complex and
(b) Copper(II)-neocuproine complex. Spectrum (a) was
formed due to reduction of CuII-neocuproine with NAC, c = 4
 10–5 mol L–1 (reference cell: deionised water).  
Figure 2. Absorbance - time curves for the proposed redox 
reaction, measured in the NAC range from 6.0 × 107 to 8.0 × 
105 mol L1. Experimental conditions: c (CuII ) = 1.0  104
mol L1 and c (neocuproine) = 2.4  104 mol L1, pH 3.0. 
Analyte was added 1 min after beginning of the measurement. 
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first order and were found to obey the following equa-
tion: 
K = ∆A /∆t = k´× cn, (2) 
where K is the reaction rate, A absorbance, t the measur-
ing time, k´ the pseudo-first order apparent rate con-
stant, c the molar concentration of NAC and n the order 
of the reaction. The logarithmic form of the above equa-
tion is written as 
log K = log (∆A /∆t ) = log k´ + nlog c. (3) 
Mathematically the initial reaction rates (K) were 
determined from the slopes of absorbance-time curves 
(∆A /∆t). The logarithms of the reaction rates (log K) 
were plotted as a function of logarithms of the NAC 
concentrations (log c) (Figure 3). 
 
Fixed-time Method. 
In this method, the absorbance of the reaction solution 
containing varying amounts of NAC was measured at a 
pre-selected fixed time. Calibration plots of the absorb-
ance versus the concentration of NAC were established 
at fixed periods of time for the reaction. During the 
optimization of the proposed method, the various time 
intervals for the absorbance measuring were observed. 
The best linearity and wider concentration range were 
achieved at the beginning of the reaction, probably 
because the reaction product is not stable, especially at 
higher concentrations. Therefore, the time interval of 1 
minute after the analyte addition was chosen. 
 
Linear Dynamic Range 
Regression analysis, using the method of least squares, 
was performed to evaluate the slope, intercept and to 
determine the coefficient of correlation (r2). For the both 
methods graphs were linear for NAC concentrations 
ranging from 6.0  10–7 to 8.0  10–5 mol L–1. For  
the initial rate method the intercept log k´ = 2.993 and 
coefficient r2 = 0.9998 were calculated. The calculated 
value of n (slope) 1.018 (≈ 1) in the regression equation 
(See Figure 3.) confirmed the first-order reaction with 
respect to the NAC concentration. For the fixed-time 
method calibration graph obeyed the equation: y = 
7111x – 0.0027, where y is the absorbance and x is 
NAC concentration expressed in mol L–1. For the both 
methods the calculated limit of detection (LOD) and the 
limit of quantification (LOQ) had the same values. LOD 
was 1.6  10–7 mol L–1 based on 3σ of the blank solution 
(n = 12). LOQ, calculated as 10σ of the 12 blank solu-
tion, was 5.4  10–7 mol L–1. 
 
Interferences Studies 
The effect of some possible interfering species was 
studied by analysing synthetic sample solutions contain-
ing 40.0 μM of NAC and various concentrations of 
interfering substances. The influence of excipients that 
can commonly accompany NAC in pharmaceutical 
formulations was also studied. The 500-fold excess 




3–) and organic acids (boric acid, tartaric acid, citric 
acid) did not interfere. An error of 5 % was considered 
to be tolerable. Similarly, 100-fold molar excess of 
sugars (glucose, fructose, sucrose and lactose) showed 
no effect on the results. It should be emphasized that 
this contaminant/analyte concentration ratio studied is 
much higher than those normally found in commercial 
pharmaceutical products.  
Although redox-active colorimetric reagents gen-
erally have limited selectivity – depending on their 
formal potential and reaction kinetics, the relative selec-
tivity of Cu(II)-neocuproine reagent was verified by its 
lack of attack on frequently present reductants: citric 
acid and reducing sugars. Interferences are, of course, 
expected from the substances possessing strong reduc-
tion properties, e.g. hydrazine or ascorbic acid. Howev-
er, reducing substances are usually not present in phar-




The accuracy of the proposed methods was checked by 
carrying out recovery studies. In this procedure, known 
amounts of NAC standard were added to preanalysed 
pharmaceutical formulation before determination by the 
recommended methods. The recoveries were in the 
range from 99 to 103 % for the both methods, as shown 
in Table 1. These results prove good accuracy of the 
proposed methods and the absence of interferences from 
common excipients. This indicates that the proposed 
kinetic methods are reliable for the determination of 
NAC in pharmaceutical preparations. 
Figure 3. Linear plot for log c vs. log K for the kinetic reac-
tion of NAC with Cu(II) – neocuproine reagent; c is the con-
centration of NAC (6.0 × 107 to 8.0 × 105 mol L1); K is the
reaction rate (s1). Please notice that the direction of the Y axis
is opposite to the direction of the X axis.  
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Application 
The applicability of the proposed methods for the de-
termination of NAC was checked by analysing several 
types of pharmaceutical formulations (syrup, dispersible 
tablets and tablets), containing different amounts of 
NAC. The concentration of NAC was computed from 
its corresponding regression equations. The results of 
the proposed methods (initial rate and fixed time) were 
compared with those obtained by official method rec-
ommended by the European Pharmacopeia2 based on 
titration of NAC with iodine (Table 2). 
Performance characteristics of reported spectro-
photometric methods, for the determination of NAC 
using classic, kinetic or flow injection setup and the 
proposed method, are compared in Table 3. 
Among the described spectrophotometric proce-
dures the most sensitive approaches to the determination 
of NAC are based on the reduction properties of analyte 
using redox-active colorimetric reagents.5,8,23,24,28–30,35 
There are few developed spectrophotometric 
methods based on the reduction of the FeIII to FeII with 
NAC, followed by the complexation of FeII with differ-
ent reagents: 1,10-phenanthroline (phen),5,23,28 ferro-
zine,8 2,4,6-trypyridyl-s-triazine (TPTZ),24,35 hexacyano-
ferrate(III)29 and ferricyanide.30 
The authors have developed kinetic spectropho-
tometric methods for determination of NAC using FeIII -
phen reagent23 and FeIII-TPTZ reagent.24 The reported 
standard potential of CuII/CuI couple in the solution of 
neocuproine (0.603 V)31 is comparable to the formal 
potential for the optimized conditions, of the FeIII / FeII 
couple in solution with TPTZ (0.578 V). The potentials 
of the above-mentioned redox-active colorimetric rea-
gents are both lower than a formal potential of FeIII / FeII 
couple in solution with 1,10-phenanthroline (1.197 V).24 
The Cu(II)-neocuproine reagent is milder and therefore 
more selective oxidant than FeIII-phenantroline reagent. 
Only the reducing substances with standard (formal) 
potentials lower than 0.6 V would have the thermody-
namic predisposition to interfere in the proposed meth-
od. On the other hand, the enhanced sensitivity of CuII-
neocuproine reagent is probably due to kinetic reasons. 
The CuI-neocuproine reagent is an immediate product of 
one-electron reduction of the reagent with NAC, while 
the described procedure with FeIII-TPTZ based on the 
reduction of iron(III) to iron(II) by NAC, followed by 
TPTZ chelation of the formed FeII requires a longer 
time. The additional advantage of CuII-neocuproine 
reagent is the absence of interference by PO4
3– ions. The 
PO4
3– ions interfere in methods based on the reduction 
of the FeIII to FeII because the phosphates make a stable 
complex with the FeIII and therefore the proposed cou-
ple redox-complexation reaction would not proceed. 
Moreover, the proposed method is proceeding in the 
acid medium i.e., Britton-Robinson buffer solution (pH 
= 3.0), where the analyte solution is more stable and the 
reduction properties of most interferences is reduced, 
thereby adding some selectivity to the proposed method. 
Table 1. Evaluation of the accuracy of the initial rate and fixed time methods of the proposed kinetic spectrophotometric method 
for determination of NAC 
Sample 












0.0 100.8 ± 0.2 – 0.0 100.2  0.3 – 
50.0 151.0 ± 0.5 100.3 50.0 149.7 ± 0.4 98.9 
100.0 203.1 ± 0.8 102.4 100.0 199.1 ± 0.7 98.9 
150.0 248.7 ± 0.9 98.6 150.0 250.1 ± 0.9 99.9 
200.0 303.8 ± 1.1 101.5 200.0 305.4 ± 0.9 102.6 
(a) Average of three determinations ± SD. 
(b) Syrup containing NAC 100 mg in 5 mL and excip.
Table 2. Content of NAC in pharmaceutical formulations determined by the official method2 and the proposed methods (initial 
rate and fixed time) 
Sample Initial rate method
(a)
m / mg 
Fixed time method(a)
m / mg 
Official method(a),2 
m / mg 
Fluimukan granules(b) 103.4  0.5 102.6  0.4 101.5  0.8 
Fluimukan Akut Junior Syrup(c) 100.8  0.2 100.2  0.3 100.3  0.6 
Fluimukan Akut Dispersible Tablets(d) 605.2  0.6 604.5  0.9 605.6  0.9 
(a) Average of three determinations ± SD. 
(b) Granules containing NAC 100 mg and excip. 
(c) Syrup containing NAC 100 mg in 5 mL and excip. 
(d) Dispersible tablets containing NAC 600 mg and excip.
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CONCLUSION 
A simple, rapid and sensitive kinetic spectrophotometric 
method for the determination of NAC has been success-
fully developed and validated. This method is based on 
the redox reaction where the analyte reduces CuII-
neocuproine complex to CuI-neocuproine complex. The 
proposed reaction is fast, temperature independent and 
can proceed in a broad pH range. Also, the kinetic of the 
proposed reaction is promising for the development of 
the flow injection method, what is the further aim of our 
research. The initial rate and fixed time (at 1 min) 
methods were utilized in this experiment. The proposed 
methods have several advantages over the previously 
reported kinetic spectrophotometric methods: wide 
linearity range of the calibration curve (over two dec-
ades, 0.6–80 μM), higher sensitivity, selectivity, speed 
(1 min for the proposed fixed time method) and straight-
forwardness compared to Ref. 25. In addition, proposed 
methods are sensitive enough to enable determination of 
near nanomole amounts of the NAC without expensive 
instruments. Application of the proposed methods to the 
determination of NAC in pharmaceutical samples has 
produced excellent results in terms of accuracy, as the 
recoveries were in the range from 99 to 103 %. 
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